Search PubMed⌕ Search

PubMed · 3767197

Cryoproteins.

Abstract

Proteins producing phenomena after exposure to the cold are reviewed but concentrating mainly on those that can produce aggregates within the laboratory. From three large series the frequencies were I. Mixed Cryoglobulins (polyclonal 50 p. 100, monoclonal 18 p. 100); II. Monoclonal Cryoglobulin (25 p. 100); III. Cryofibrinogen (3 p. 100) and IV. Cold Agglutinins (polyclonal 2 p. 100, monoclonal 2 p. 100). Mixed cryoglobulins present with any of the features of immune complex disease, but with the onset of renal involvement, over 50 p. 100 of the patients are dead within 5 years. Monoclonal cryoglobulins present with flat lesions in dependent areas, most reflecting an underlying or impending malignant B-cell neoplasm. Cryofibrinogen, missed in heparinised samples, is associated with thrombophlebitis migrans and sometimes underlying cancer, especially of the pancreas. Cold agglutinins cause Raynaud's phenomenon and haemolytic anaemia and the blood must be centrifuged at 37 degrees C. Treatments are discussed and are certainly encouraging in about one-third of the patients.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J R Hobbs. 1986. Cryoproteins.. https://pubmed.ncbi.nlm.nih.gov/3767197/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia.

We describe a female with a history of autosomal recessive hyper-IgM (HIGM) syndrome along with a history of autoimmune hemolytic anemia and intermittent lymphadenopathy. She subsequently developed neutropenia, lymphocyostosis and mild thrombocytopenia. Flow cytometry of the peripheral blood revealed the presence of a marked predominance of cytotoxic T lymphocytes, shown to be clonal, with concomitant natural killer (NK) antigen expression. She responded to weekly methotrexate therapy.

Anemia, Hemolytic, Autoimmune↗

Controlling autoimmunity--Lessons from the study of red blood cells as model antigens.

The characterization of human and animal red blood cell (RBC) autoantigens in autoimmune hemolytic anemia (AIHA) has provided an opportunity study the control of specific autoimmune responses of unequivocal pathogenic relevance. The results reveal that censorship of the autoimmune helper T (Th) cell repertoire by deletion and anergy is very incomplete in healthy individuals, even for widely distributed, abundant self-antigens on RBC. There is strong evidence that autoaggression by surviving Th cells is normally held in check by other mechanisms, including failure to display the epitopes that they recognize, and active immunoregulation. AIHA is one of the first human autoimmune diseases in which regulatory T (Tr) cells that are specific for the major autoantigens have been identified. These Tr cells recognize the dominant naturally processed epitopes, and recent studies suggest that disease develops when other determinants, to which such tolerance is less secure, and which are normally inefficiently presented, are displayed at higher levels. Together, the results raise the possibility that therapy for diseases such as AIHA could be based on switching the balance of the response back towards regulation, in particular by the administration of the dominant peptides recognized by specific Tr cells.

Anemia, Hemolytic, Autoimmune↗